Chemomab Therapeutics Ltd. (CMMB)
Pharmaceutical Preparations
Latest Price
$1.53
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.13
P/B Ratio
12.09
Valuation metrics
adjust assumptions →EPS: $0.02
Book value / share: $0.33
Formula: √(22.5 × EPS × BVPS)
Graham Number
$0.37
76% downside
EPS: $0.02
Target P/E: 15×
Formula: EPS × P/E
P/E Fair Value
$0.27
82% downside
Institutional Ownership
0.1% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 80.0K | -- | 0.02% | -- | 2026-03-31 |
| CITADEL ADVISORS LLC | 64.2K | -- | 0.01% | -39.6K | 2026-03-31 |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 61.7K | -- | 0.01% | +10.0K | 2026-03-31 |
| Ikarian Capital, LLC | 51.8K | -- | 0.01% | -- | 2026-03-31 |
| XTX Topco Ltd | 18.6K | -- | 0.00% | -384 | 2026-03-31 |
| RHUMBLINE ADVISERS | 18.4K | -- | 0.00% | +510 | 2026-03-31 |
| BNP PARIBAS FINANCIAL MARKETS | 8.4K | -- | 0.00% | +300 | 2026-03-31 |
| Philadelphia Investment Partners, LLC | 8.2K | -- | 0.00% | -- | 2026-03-31 |
| GAMMA Investing LLC | 7.6K | -- | 0.00% | +5.1K | 2026-03-31 |
| MORGAN STANLEY | 4.6K | -- | 0.00% | +800 | 2026-03-31 |